Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

Build and Download Custom Datasets

refine.bio helps you build ready-to-use datasets with normalized transcriptome data from all of the world’s genetic databases.

SRP051814

Mus musculus

8 Downloadable Samples

Illumina HiSeq 2000

Submitter Supplied Information

Description

We perform RNA-seq on matched orthotopic murine primary and metastatic prostate cancer samples to identify differential gene expressions Overall design: RNA-seq was performed on orthotopic murine primary and metastatic tumor samples using Illumina Hi-Seq 2000 platform

PubMed ID

25605014

Publication Title

Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer.

Total Samples

Submitter’s Institution

No associated institution

Authors

Kirk JS, Schaarschuch K, Dalimov Z, Lasorsa E, Ku S, Ramakrishnan S, Hu Q, Azabdaftari G, Wang J, Pili R, Ellis L

Source Repository

Sequence Read Archive (SRA)

No rows found